Need professional-grade analysis? Visit stockanalysis.com
$329.51M
15.33
999
N/A
Medios AG (ILM1) trades on XETRA (Frankfurt) in EUR. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at EUR13.80, up 3.45% from the previous close.
Over the past year, ILM1 has traded between a low of EUR11.28 and a high of EUR17.32. The stock has gained 21.7% over this period. It is currently 20.3% below its 52-week high.
Medios AG has a market capitalization of $329.51M, with a price-to-earnings ratio of 15.33.
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.
Side-by-side comparison against top Healthcare peers.